| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 2002;123:280-287
© 2002 The American Association for Thoracic Surgery
General Thoracic Surgery (GTS) |
From the Department of Surgery, Division of Cardiothoracic Surgery,a and the Department of Otolaryngology-Head and Neck Surgery,b Washington University School of Medicine, St Louis, Mo.
Received for publication May 14, 2001. Revisions requested June 18, 2001; revisions received July 20, 2001. Accepted for publication July 24, 2001. Address for reprints: Richard J. Battafarano, MD, PhD, One Barnes-Jewish Plaza, 3107 Queeny Tower, St Louis, MO 63110-1013 (E-mail: battafarano{at}msnotes.wustl.edu).
Objective: As the mean age in patients with non–small cell lung cancer increases, the proportion of patients with serious comorbidity who are considered for surgical resection also increases. Patients with non–small cell lung cancer have been shown to have a higher burden of comorbidity than do patients with tumors of other sites, such as breast, prostate, colon, and head and neck. The goal of this review was to determine the impact of comorbidity on postoperative and long-term survival after surgical resection in patients with stage I non–small cell lung cancer.
Methods: A database analysis of our hospital's tumor registry included 451 patients who underwent surgical resection for pathologic stage I non–small cell lung cancer between January 1, 1994, and December 31, 1999. Comorbidity severity was prospectively determined with the Kaplan-Feinstein Index. Survival data were collected for each patient from the date of operation, with a mean duration of follow-up of 35.7 months. Bivariate statistics and Cox proportional hazards model analyses were used.
Results: The mean age was 64.4 years, and 249 (55%) patients were male. The distribution of overall comorbidity severity was none, 142 (31.5%); mild, 150 (33.3%); moderate, 115 (25.5%); and severe, 44 (9.8%). The overall in-hospital mortality was 2.2% (n = 10/451). There was a nonsignificant trend toward higher hospital mortality with greater comorbidity: none, 0.7% (n = 1/142); mild, 3.3% (n = 5/150); moderate, 0.9% (n = 1/115); and severe, 6.8% (n = 3/44, P = .055). Kaplan-Meier estimated survivals at 3 years for each level of comorbidity were as follows: none, 85.6%; mild, 74.8%; moderate, 68.8%; and severe, 70.0% (P < .002). After adjustment for age, sex, T status, and tumor histologic type, the relative risks of death as a function of comorbidity were mild, 1.44 (95% confidence interval 0.89-2.34); moderate, 2.28 (95% confidence interval 1.43-3.65); and severe; 1.94 (95% confidence interval 1.023-3.70).
Conclusions: Comorbidity has a significant impact on survival after surgical resection of patients with stage I non–small cell lung cancer. These data may help to explain the lower than expected survival results for patients after surgical resection for stage I non–small cell lung cancer.
This article has been cited by other articles:
|
|
 |
|
  T. Nakagawa, N. Okumura, K. Ohata, H. Igai, T. Matsuoka, and K. Kameyama Postrecurrence survival in patients with stage I non-small cell lung cancer Eur. J. Cardiothorac. Surg., September 1, 2008; 34(3): 499 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Farjah, D. E. Wood, D. Yanez III, R. G. Symons, B. Krishnadasan, and D. R. Flum Temporal trends in the management of potentially resectable lung cancer. Ann. Thorac. Surg., June 1, 2008; 85(6): 1850 - 1855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Jones and C. C. Doebbeling Beyond the Traditional Prognostic Indicators: The Impact of Primary Care Utilization on Cancer Survival J. Clin. Oncol., December 20, 2007; 25(36): 5793 - 5799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-Y. Wang, Y.-S. Lin, C. Tzao, H.-C. Lee, M.-H. Huang, W.-H. Hsu, and H.-S. Hsu Comparison of Charlson comorbidity index and Kaplan Feinstein index in patients with stage I lung cancer after surgical resection Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 877 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-E. Strand, H. Rostad, R. A M Damhuis, and J. Norstein Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude Thorax, November 1, 2007; 62(11): 991 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Raz, J. A. Zell, S-H. I. Ou, D. R. Gandara, H. Anton-Culver, and D. M. Jablons Natural History of Stage I Non-Small Cell Lung Cancer: Implications for Early Detection Chest, July 1, 2007; 132(1): 193 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lopez-Encuentra, A. Gomez de la Camara, R. Rami-Porta, J. L. Duque-Medina, J. L. M. de Nicolas, J. Sayas, and the Bronchogenic Carcinoma Cooperative Group of th Previous tumour as a prognostic factor in stage I non-small cell lung cancer Thorax, May 1, 2007; 62(5): 386 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Birim, A. P. Kappetein, M. Waleboer, J. P.A. Puvimanasinghe, M. J.C. Eijkemans, E. W. Steyerberg, M. I.M. Versteegh, and A. J.J.C. Bogers Long-term survival after non-small cell lung cancer surgery: Development and validation of a prognostic model with a preoperative and postoperative mode. J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 491 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sugimura and P. Yang Long-term Survivorship in Lung Cancer: A Review. Chest, April 1, 2006; 129(4): 1088 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Birim, A. P. Kappetein, and A. J.J.C. Bogers Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer Eur. J. Cardiothorac. Surg., November 1, 2005; 28(5): 759 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Moro-Sibilot, A. Aubert, S. Diab, S. Lantuejoul, P. Fourneret, E. Brambilla, C. Brambilla, and P. Y. Brichon Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer Eur. Respir. J., September 1, 2005; 26(3): 480 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lopez-Encuentra, J. Astudillo, J. Cerezal, F. Gonzalez-Aragoneses, N. Novoa, A. Sanchez-Palencia, and Bronchogenic Carcinoma Cooperative Group of the Sp Prognostic value of chronic obstructive pulmonary disease in 2994 cases of lung cancer Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 8 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Makrantonakis, E. Galani, and P. G. Harper Non-Small Cell Lung Cancer in the Elderly Oncologist, September 1, 2004; 9(5): 556 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. L. Read, R. M. Tierney, N. C. Page, I. Costas, R. Govindan, E. L.J. Spitznagel, and J. F. Piccirillo Differential Prognostic Impact of Comorbidity J. Clin. Oncol., August 1, 2004; 22(15): 3099 - 3103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M L G Janssen-Heijnen, S Smulders, V E P P Lemmens, F W J M Smeenk, H J A A van Geffen, and J W W Coebergh Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer Thorax, July 1, 2004; 59(7): 602 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Humphrey, S. Teutsch, and M. Johnson Lung Cancer Screening with Sputum Cytologic Examination, Chest Radiography, and Computed Tomography: An Update for the U.S. Preventive Services Task Force Ann Intern Med, May 4, 2004; 140(9): 740 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Battafarano, S. D. Force, B. F. Meyers, J. Bell, T. J. Guthrie, J. D. Cooper, and G. A. Patterson Benefits of resection for metachronous lung cancer J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 836 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chiyo, Y. Sekine, T. Iwata, K. Tatsumi, K. Yasufuku, A. Iyoda, M. Otsuji, S. Yoshida, K. Shibuya, T. Iizasa, et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 1141 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Alifano, M. D'Aiuto, P. Magdeleinat, E. Poupardin, A. Chafik, S. Strano, and J. F. Regnard Surgical Treatment of Superior Sulcus Tumors: Results and Prognostic Factors Chest, September 1, 2003; 124(3): 996 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, W. Nishio, T. Sakamoto, H. Harada, K. Uchino, and N. Tsubota Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 558 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Jeremic Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 444 - 445. [Full Text] [PDF]
|
|
|
|
|
|
O. Birim, A.P.W.M. Maat, A.P. Kappetein, J.P. van Meerbeeck, R.A.M. Damhuis, and A.J.J.C. Bogers Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer Eur. J. Cardiothorac. Surg., January 1, 2003; 23(1): 30 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Battafarano, B. F. Meyers, T. J. Guthrie, J. D. Cooper, and G. A. Patterson Surgical resection of multifocal non-Small cell lung cancer is associated with prolonged survival Ann. Thorac. Surg., October 1, 2002; 74(4): 988 - 994. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
